Aigen Investment Management’s Transmedics TMDX Stock Holding History

Aigen Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$218K	Buy	+2,194	New	+$286K	0.06%	412
2025 Q4	–	Sell	-3,658	Closed	-$410K	–	976
2025 Q3	$410K	Buy	+3,658	New	+$428K	0.06%	451
2025 Q1	–	Sell	-4,000	Closed	-$249K	–	1032
2024 Q4	$249K	Buy	4,000 +670	+20%	+$62.4K	0.04%	536
2024 Q3	$523K	Buy	+3,330	New	+$513K	0.1%	309
2024 Q1	–	Sell	-12,377	Closed	-$977K	–	1013
2023 Q4	$977K	Sell	12,377 -1,866	-13%	-$113K	0.17%	159
2023 Q3	$780K	Buy	+14,243	New	+$1.03M	0.15%	225
2023 Q1	–	Sell	-3,439	Closed	-$212K	–	832
2022 Q4	$212K	Buy	+3,439	New	+$183K	0.03%	442

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aigen Investment Management's TMDX Position: Q1 2026 in Review

Aigen Investment Management opened a new position in Transmedics (TMDX) in Q1 2026: 2,194 shares worth $218K. The stake represents 0.06% of the portfolio and ranks #412 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in TMDX as recently as Q3 2025.

Aigen Investment Management first reported a position in TMDX in Q4 2022 and has held it in 7 quarters since. The position peaked at $977K in Q4 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Aigen Investment Management held 2,194 shares of Transmedics worth $218K as of Q1 2026.
Transmedics was a new Aigen Investment Management position in Q1 2026.
Transmedics made up 0.06% of Aigen Investment Management's portfolio in Q1 2026, its #412 holding.
Aigen Investment Management first reported a position in Transmedics in Q4 2022 and has held it in 7 quarters since.
Aigen Investment Management's Transmedics position peaked at $977K in Q4 2023.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.